首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1317篇
  免费   152篇
  国内免费   2篇
耳鼻咽喉   3篇
儿科学   26篇
妇产科学   2篇
基础医学   30篇
口腔科学   3篇
临床医学   470篇
内科学   582篇
皮肤病学   15篇
神经病学   82篇
特种医学   14篇
外国民族医学   1篇
外科学   39篇
综合类   59篇
预防医学   71篇
眼科学   10篇
药学   44篇
  1篇
中国医学   5篇
肿瘤学   14篇
  2024年   1篇
  2023年   9篇
  2022年   14篇
  2021年   37篇
  2020年   39篇
  2019年   105篇
  2018年   126篇
  2017年   59篇
  2016年   56篇
  2015年   61篇
  2014年   138篇
  2013年   107篇
  2012年   65篇
  2011年   77篇
  2010年   74篇
  2009年   77篇
  2008年   71篇
  2007年   74篇
  2006年   41篇
  2005年   36篇
  2004年   37篇
  2003年   23篇
  2002年   23篇
  2001年   17篇
  2000年   15篇
  1999年   21篇
  1998年   16篇
  1997年   15篇
  1996年   6篇
  1995年   4篇
  1994年   1篇
  1993年   5篇
  1992年   5篇
  1991年   4篇
  1990年   3篇
  1989年   2篇
  1987年   1篇
  1985年   2篇
  1983年   1篇
  1980年   2篇
  1979年   1篇
排序方式: 共有1471条查询结果,搜索用时 296 毫秒
11.
The early-stage assessment of the physical stability of new monoclonal antibodies in different formulations is often based on high-throughput techniques that suffer from various drawbacks. Accordingly, new approaches that facilitate the protein formulation development can be of high value to the industry. In this study, a dynamic light scattering plate reader is used to measure the aggregation (by means of the increase in the hydrodynamic radius [Rh]) of monoclonal antibody samples that were subject to incubation and subsequent dilution from different concentrations of a denaturing agent, that is, guanidine hydrochloride. The increase in the Rh of the protein samples is dependent not only on the denaturant concentration used but also on the buffer in which the incubation/dilution was performed. We also compare the aggregation after dilution from a denaturant with other high-throughput stability-indicating methods and find good agreement between the techniques. The proposed approach to probe the physical stability of monoclonal antibodies in different formulation conditions offers a unique combination of features—it is isothermal, probes both the resistance to denaturant-induced unfolding and the colloidal protein stability, it is entirely label-free, does not rely on complex data evaluation, and requires very short instrument measurement time on standard equipment.  相似文献   
12.
13.
14.
15.
目的:通过深入分析骨折疾病的分类,探讨规范不同类型骨折疾病的病案编码方法。方法:通过文献调研,统筹概括各种情形的骨折类疾病的性质和编码方法。结果:提出系统性的骨折类疾病编码流程,方便编码和信息统计人员使用。结论:骨折类疾病病因复杂,多数病种未能概括,编码人员在临床实际编码过程中需认真阅读病案资料,对骨折真正类别进行准确编码。  相似文献   
16.

Background

Patients undergoing surgical aortic valve replacement (SAVR) are considered at high risk of infective endocarditis (IE). However, data on the risk of IE following transcatheter aortic valve replacement (TAVR) are sparse and limited by the lack of long-term follow-up as well as a direct comparison with patients undergoing SAVR.

Objectives

This study sought to investigate the long-term incidence of IE in patients undergoing TAVR and to compare the long-term risk of IE with patients undergoing isolated SAVR.

Methods

In this nationwide observational cohort study, all patients undergoing TAVR and isolated SAVR from January 1, 2008, to December 31, 2016, with no history of IE and alive at discharge were identified using data from Danish nationwide registries.

Results

A total of 2,632 patients undergoing TAVR and 3,777 patients undergoing isolated SAVR were identified. During a mean follow-up of 3.6 years, 115 patients (4.4%) with TAVR and 186 patients (4.9%) with SAVR were admitted with IE. The median time from procedure to IE hospitalization was 352 days (25th to 75th percentile: 133 to 778 days) in the TAVR group and 625 days (25th to 75th percentile: 209 to 1,385 days) in the SAVR group. The crude incidence rates of IE were 1.6 (95% confidence interval [CI]: 1.4 to 1.9) and 1.2 (95% CI: 1.0 to 1.4) events per 100 person-years in TAVR and SAVR patients, respectively. The cumulative 1-year risk of IE was 2.3% (95% CI: 1.8% to 2.9%) and 1.8% (95% CI: 1.4% to 2.3%) in TAVR and SAVR patients, respectively. Correspondingly, the cumulative 5-year risk of IE was 5.8% (95% CI: 4.7% to 7.0%) and 5.1% (95% CI: 4.4% to 6.0%), respectively. In multivariable Cox proportional hazard analysis, TAVR was not associated with a statistically significant different risk of IE compared with SAVR (hazard ratio: 1.12; 95% CI: 0.84 to 1.49).

Conclusions

The 5-year incidence of IE following TAVR was 5.8% and not significantly different than the incidence following SAVR.  相似文献   
17.

Background

Information on young patients with Brugada syndrome (BrS) and arrhythmic events (AEs) is limited.

Objectives

The purpose of this study was to describe their characteristics and management as well as risk factors for AE recurrence.

Methods

A total of 57 patients (age ≤20 years), all with BrS and AEs, were divided into pediatric (age ≤12 years; n = 26) and adolescents (age 13 to 20 years; n = 31).

Results

Patients’ median age at time of first AE was 14 years, with a majority of males (74%), Caucasians (70%), and probands (79%) who presented as aborted cardiac arrest (84%). A significant proportion of patients (28%) exhibited fever-related AE. Family history of sudden cardiac death (SCD), prior syncope, spontaneous type 1 Brugada electrocardiogram (ECG), inducible ventricular fibrillation at electrophysiological study, and SCN5A mutations were present in 26%, 49%, 65%, 28%, and 58% of patients, respectively. The pediatric group differed from the adolescents, with a greater proportion of females, Caucasians, fever-related AEs, and spontaneous type-1 ECG. During follow-up, 68% of pediatric and 64% of adolescents had recurrent AE, with median time of 9.9 and 27.0 months, respectively. Approximately one-third of recurrent AEs occurred on quinidine therapy, and among the pediatric group, 60% of recurrent AEs were fever-related. Risk factors for recurrent AE included sinus node dysfunction, atrial arrhythmias, intraventricular conduction delay, or large S-wave on ECG lead I in the pediatric group and the presence of SCN5A mutation among adolescents.

Conclusions

Young BrS patients with AE represent a very arrhythmogenic group. Current management after first arrhythmia episode is associated with high recurrence rate. Alternative therapies, besides defibrillator implantation, should be considered.  相似文献   
18.
19.
20.
卓文敏 《现代医院》2013,13(6):138-139
1981年至今,人类已确认可感染人的禽流感病毒有H7N7、H5N1、H9N2、H7N2、H7N3、H5N2、H10N7、H7N9八种,其临床表现和病死率相差悬殊,而ICD-10(2008年第2版)提供的人禽流感编码只有类目J09,随着威胁人类的高病死率人禽流感的出现,建议适当增加亚目对人禽流感疾病进行分类,以利于死亡和疾病数据进行系统记录、分析、解释和比较。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号